Cargando…

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis

Introduction: Cerebral venous thrombosis (CVT) is a life-threatening neurological condition. There is limited evidence for the use of direct oral anticoagulants (DOAC) for long-term anticoagulation in this patient population. We report a case series of patients treated with apixaban and their clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bharath, Suman Preet, Arshad, Hasnain, Song, Yong-Bum, Kirmani, Jawad F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893101/ https://www.ncbi.nlm.nih.gov/pubmed/36700247 http://dx.doi.org/10.1177/10760296221129591

Ejemplares similares

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Efficacy and Safety Assessment of Rivaroxaban for the Treatment of Cerebral Venous Sinus Thrombosis in a Chinese Population
por: Jiang, Yi-ying, et al.
Publicado: (2022)

Efficacy and risks of anticoagulation for cerebral venous thrombosis
por: Xu, Weilin, et al.
Publicado: (2018)

Development of New Deep Venous Thrombosis While on Apixaban
por: Sharma, Munish, et al.
Publicado: (2017)

Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion
por: Ge, Heng, et al.
Publicado: (2022)

Clinical Efficacy of Conventional Heparin Anticoagulation Combined with Apixaban in the Treatment of Patients with Cerebral Venous Thrombosis and Its Effect on Serum D-Dimer and FIB Expression
por: Dong, Xiaohui, et al.
Publicado: (2021)

The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study
por: Cao, Xiangyu, et al.
Publicado: (2021)

Anticoagulation Therapy for Splanchnic Vein Thrombosis Associated With Acute Pancreatitis: A Systematic Review and Meta-Analysis
por: Yin, Yuhang, et al.
Publicado: (2023)

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis
por: Salehi Omran, Setareh, et al.
Publicado: (2023)

Hepatocyte-derived Microparticles as Novel Biomarkers for the Diagnosis of Deep Venous Thrombosis in Trauma Patients
por: Zang, Xinwei, et al.
Publicado: (2023)

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis
por: Mehrotra, Siddharth, et al.
Publicado: (2022)

Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Preoperative Venous Thromboembolism Screening and Postoperative Selective Anticoagulant Therapy Effectively Prevents Postoperative Symptomatic Venous Thromboembolism in Gynecological Malignancies: A 15-Year, Single-Center Study
por: Tasaka, Nobutaka, et al.
Publicado: (2023)

Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis
por: Ghandehari, Kavian, et al.
Publicado: (2013)

Cerebral venous sinus thrombosis in homocystinuria: Dietary intervention in conjunction with anticoagulation
por: Yap, Sufin, et al.
Publicado: (2017)

Anticoagulation delay does not affect the functional outcome of cerebral venous thrombosis
por: Ji, Kangxiang, et al.
Publicado: (2020)

Association Between Monocyte Count and Preoperative Deep Venous Thrombosis in Older Patients with hip Fracture: A Retrospective Study
por: Wang, Zhicong, et al.
Publicado: (2022)

Association Between Blood Lipid Levels and Lower Extremity Deep Venous Thrombosis: A Population-Based Cohort Study
por: Huang, Yiming, et al.
Publicado: (2022)

Aftermath of Apixaban: Atypical Anticoagulation Aftereffect
por: Karki, Bhesh, et al.
Publicado: (2022)

The Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Deep Venous Thrombosis: A Systematic Review and Meta-Analysis
por: Hu, Chenming, et al.
Publicado: (2023)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
por: Bose, Gauruv, et al.
Publicado: (2021)

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists
por: Rodriguez, Vilmarie, et al.
Publicado: (2022)

Term Infant with Cerebral Venous Sinus Thrombosis
por: Jani, Sanket, et al.
Publicado: (2020)

Calibration and validation of the rabbit model of electrolytic‐mediated arterial thrombosis against the standard‐of‐care anticoagulant apixaban
por: Wong, Pancras C., et al.
Publicado: (2022)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol
por: Bose, Gauruv, et al.
Publicado: (2019)

The outcomes of pregnant and postpartum patients with cerebral venous sinus thrombosis after anticoagulant therapy
por: Meng, Shi-Hui, et al.
Publicado: (2021)

Cerebral venous thrombosis
por: Moraes, Anisio Adalio de Azevedo, et al.
Publicado: (2022)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Inflammation in Cerebral Venous Thrombosis
por: Ding, Jiayue, et al.
Publicado: (2022)

Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis
por: Cohen, A. T., et al.
Publicado: (2015)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Management of Haemarthrosis in Patients On Oral Anticoagulants
por: Dalrymple, James, et al.
Publicado: (2022)

Visual Acuity in Patients Requiring Intravitreal Injections: Short-Term and Long-Term Effects of Delay in Care
por: Song, Weilin, et al.
Publicado: (2022)

Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis.
por: Klein, David E., et al.
Publicado: (2020)

Anticoagulation treatment and prophylactic edoxaban for cerebral sinus venous thrombosis in an adolescent with acute lymphoblastic leukemia
por: Koganesawa, Masaya, et al.
Publicado: (2021)

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial
por: Liu, Xianchen, et al.
Publicado: (2015)

Batroxobin in combination with anticoagulation may promote venous sinus recanalization in cerebral venous thrombosis: A real‐world experience
por: Ding, Jia‐Yue, et al.
Publicado: (2019)

Idiopathic pulmonary vein thrombosis treated with apixaban
por: Ngo, Dallis, et al.
Publicado: (2021)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s1f26kai45iqlbqm9a64bpd6af